Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Corey

Showing results (151-160 of 222) with videos related to

Pageof 23
Sort By:
Oncogene|August 15, 2019
Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancerSubing Cao, Tianfang Ma, Nathan Ungerleider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate CancerDiana C DeLucia, Thomas M Cardillo, Lisa Ang, et al.
The Journal of Clinical Investigation|March 17, 2026
Targeting Wnt/β-Catenin and circadian regulator restores PRC2/EZH2 controlled chromatin bivalency and suppresses cell state diversityYatian Yang, Xiong Zhang, Varadha Balaji Venkadakrishnan, et al.
The Journal of Clinical Investigation|April 15, 2026
Therapeutic targeting of the eIF4E cap-binding domain reveals control of lineage fate in prostate cancerRashmi Mishra, Sihyeon Song, Dhruv Choradia, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2011
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancersAkash Kumar, Thomas A White, Alexandra P MacKenzie, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategiesSander Frank, Thomas Persse, Ilsa Coleman, et al.
Nature Reviews. Urology|January 17, 2023
The future of patient-derived xenografts in prostate cancer researchMitchell G Lawrence, Renea A Taylor, Georgia B Cuffe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2018
Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate CancerElahe A Mostaghel, Ailin Zhang, Susana Hernandez, et al.
Molecular Cancer Research : MCR|October 17, 2024
N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic PhenotypeJoseph E Ippolito, Jordan P Hartig, Kaitlyn Bejar, et al.
The Journal of Clinical Investigation|June 24, 2025
BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature-positive castration-resistant prostate cancerShipra Shukla, Dan Li, Woo Hyun Cho, et al.
Pageof 23

Showing results (151-160 of 222) with videos related to

Sort By:
Pageof 23
Oncogene|August 15, 2019
Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancerSubing Cao, Tianfang Ma, Nathan Ungerleider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate CancerDiana C DeLucia, Thomas M Cardillo, Lisa Ang, et al.
The Journal of Clinical Investigation|March 17, 2026
Targeting Wnt/β-Catenin and circadian regulator restores PRC2/EZH2 controlled chromatin bivalency and suppresses cell state diversityYatian Yang, Xiong Zhang, Varadha Balaji Venkadakrishnan, et al.
The Journal of Clinical Investigation|April 15, 2026
Therapeutic targeting of the eIF4E cap-binding domain reveals control of lineage fate in prostate cancerRashmi Mishra, Sihyeon Song, Dhruv Choradia, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2011
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancersAkash Kumar, Thomas A White, Alexandra P MacKenzie, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategiesSander Frank, Thomas Persse, Ilsa Coleman, et al.
Nature Reviews. Urology|January 17, 2023
The future of patient-derived xenografts in prostate cancer researchMitchell G Lawrence, Renea A Taylor, Georgia B Cuffe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2018
Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate CancerElahe A Mostaghel, Ailin Zhang, Susana Hernandez, et al.
Molecular Cancer Research : MCR|October 17, 2024
N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic PhenotypeJoseph E Ippolito, Jordan P Hartig, Kaitlyn Bejar, et al.
The Journal of Clinical Investigation|June 24, 2025
BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature-positive castration-resistant prostate cancerShipra Shukla, Dan Li, Woo Hyun Cho, et al.
Pageof 23